Literature DB >> 27847207

Effect of patchouli (Pogostemon cablin) essential oil on in vitro and in vivo leukocytes behavior in acute inflammatory response.

Saulo Euclides Silva-Filho1, Luiz Alexandre Marques Wiirzler2, Heitor Augusto Otaviano Cavalcante2, Nancy Sayuri Uchida2, Francielli Maria de Souza Silva-Comar2, Gabriel Fernando Esteves Cardia2, Expedito Leite da Silva3, Rafael Pazinatto Aguiar2, Ciomar Aparecida Bersani-Amado2, Roberto Kenji Nakamura Cuman2.   

Abstract

PURPOSE: The aim of this study was to evaluate the effect of Pogostemon cablin essential oil (PEO) on leukocyte behavior in the inflammatory response. METHODS AND
RESULTS: PEO was analyzed using Gas Chromatography/Mass Spectrometry (GC/SM) and Nuclear Magnetic Resonance Spectroscopy (NMR) methods and showed predominance of patchoulol (38.50%), α-bulnesene (20.37%), α-guaiene (12.31%), seychellene (8.33%) and α-patchoulene (4.91%). PEO at concentrations of 1, 3, 10, 30, 60 and 90μg/ml reduced the in vitro neutrophil chemotaxis toward fMLP, and at concentrations of 3 and 10μg/ml, increased the phagocytic activity of neutrophils. Topical application of PEO in high concentrations promoted an increase of ear edema and myeloperoxidase (MPO) activity. However, the oral treatment with 100, 200 and 300mg/kg reduced leukocyte recruitment, nitric oxide (NO) production, and rolling and adherent leukocyte number in the microcirculation.
CONCLUSION: PEO affects the leukocyte behavior, and the mechanism proposed of PEO seems to be, at least in part, involving the participation of NO and pro-inflammatory cytokines.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Leukocytes; Natural products; Patchouli; Sesquiterpenes

Mesh:

Substances:

Year:  2016        PMID: 27847207     DOI: 10.1016/j.biopha.2016.10.084

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Effect of (-)-α-Bisabolol on the Inflammatory Response in Systemic Infection Experimental Model in C57BL/6 Mice.

Authors:  Heitor Augusto Otaviano Cavalcante; Saulo Euclides Silva-Filho; Luiz Alexandre Marques Wiirzler; Gabriel Fernando Esteves Cardia; Nancy Sayuri Uchida; Francielli Maria de Souza Silva-Comar; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Effect of Ylang-Ylang (Cananga odorata Hook. F. & Thomson) Essential Oil on Acute Inflammatory Response In Vitro and In Vivo.

Authors:  Robson Araújo de Freitas Junior; Paloma Kênia de Moraes Berenguel Lossavaro; Cândida Aparecida Leite Kassuya; Edgar Julian Paredes-Gamero; Nelson Carvalho Farias Júnior; Maria Inês Lenz Souza; Francielli Maria de Souza Silva-Comar; Roberto Kenji Nakamura Cuman; Denise Brentan Silva; Mônica Cristina Toffoli-Kadri; Saulo Euclides Silva-Filho
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

Review 3.  Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review.

Authors:  Chen Junren; Xie Xiaofang; Li Mengting; Xiong Qiuyun; Li Gangmin; Zhang Huiqiong; Chen Guanru; Xu Xin; Yin Yanpeng; Peng Fu; Peng Cheng
Journal:  Chin Med       Date:  2021-01-07       Impact factor: 5.455

4.  Spectrum-Efficacy Relationships between GC-MS Fingerprints of Essential Oil from Valerianae Jatamansi Rhizoma et Radix and the Efficacy of Inhibiting Microglial Activation.

Authors:  Nan-Yun Yang; Qi-Rui Li; Xu Zhang; Fan-Li Zeng; Xiang-Chun Shen; Qing-De Long
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

5.  Succinum extracts inhibit microglial-derived neuroinflammation and depressive-like behaviors.

Authors:  Ji-Yun Kang; Dong-Cheol Baek; Chang-Gue Son; Jin-Seok Lee
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

6.  Effect of Lavender (Lavandula angustifolia) Essential Oil on Acute Inflammatory Response.

Authors:  Gabriel Fernando Esteves Cardia; Saulo Euclides Silva-Filho; Expedito Leite Silva; Nancy Sayuri Uchida; Heitor Augusto Otaviano Cavalcante; Larissa Laila Cassarotti; Valter Eduardo Cocco Salvadego; Ricardo Alexandre Spironello; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-18       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.